Skip to content

Lung Cancer Screening CT for Firefighters

Early Cancer Detection in Firefighters With Low-Dose Chest CT: A Community-Based Approach

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06836414
Enrollment
1200
Registered
2025-02-20
Start date
2026-03-31
Completion date
2035-12-31
Last updated
2025-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoke Inhalation, Exposure, Inhalation, Exposure to Pollution, Exposure Occupational, Lung Diseases, Lung Cancer, Lung Diseases, Interstitial, Occupational Exposure, Occupational Lung Disease, Interstitial Lung Disease

Keywords

Population research, Cancer Screening

Brief summary

Firefighters are at increased risk for cancer due to exposure to carcinogenic substances. Current lung cancer screening guidelines are predominantly based on smoking history and do not take into account high risk occupational exposures such as firefighting. This study aims to provide chest computed tomography (CT) scans to firefighters to determine the prevalence of lung cancer, other cancers detectable on CT chest, and lung diseases associated with increased cancer risk.

Detailed description

This is a single-group prospective interventional study and a community-based participatory project led by University of California, San Francisco and in close collaboration with the firefighter community in California. PRIMARY OBJECTIVE: I. Determine the prevalence of lung cancer, other cancers and cancer risk factors detectable on chest Computerized Tomography (CT) (Aim 1). II. Identify imaging and non-imaging predictors of lung cancer and other cancers detectable on chest CT. SECONDARY OBJECTIVE: I. Determine the prevalence of incidental findings on chest CT (Aim 1). II. Determine the risk factors for cancer development in firefighters (Aim 2). EXPLORATORY OBJECTIVES: I. Long term follow-up to determine the incidence of lung cancer and other cancers among firefighters. II. Develop a firefighter cancer imaging registry. OUTLINE: Participants will be administered a single, low dose chest CT to included participants and collect comprehensive demographic, clinical, and occupational data. Participants will be followed up at 1-2 months, for at least 1 year and up to 10 years to collect any follow-up imaging and biopsy results, if applicable.

Interventions

PROCEDURELow-dose Computerized tomography (CT) of Chest

Undergo CT for lung cancer screening

OTHERQuestionnaires

Participants will complete questionnaires on or before the day of the scan.

Medical history will be obtained in person and via medical record review

Sponsors

Hayward Firefighters Local 1909 of the International Association of Firefighters
CollaboratorUNKNOWN
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age 35 years or greater. If the participant is above the age of 80, participants must be otherwise healthy and well-fit to undergo treatment if lung cancer were to be discovered. 2. Never smoker or quit more than 15 years ago. 3. Able to understand study procedures and to comply with them for the entire length of the study. 4. Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it. 5. Length in profession for 10 or more years. This includes both volunteer firefighting and professional firefighting, self-attested as verifiable by professional records. Additional cases for Aim 2: 1. Age 18+, may include deceased firefighters. 2. A previous or current history of confirmed thoracic malignancy (except localized skin cancer, cancer in situ, or other localized cancers)

Exclusion criteria

* Aim 1: 1. Contraindication to any study-related procedure or assessment. 2. Personal history of malignancy within 5 years (except localized skin cancer, cancer in situ, or localized cancers that are definitively treated and are unlikely to recur) or lung cancer at any time. 3. Participants will be assessed for active pregnancy per standard procedure for clinical lung cancer screening CT at University of California, San Francisco which includes asking the participants directly along with documentation of whether the negative pregnancy was self-reported or confirmed with a urine pregnancy test. 4. Prior CT chest within 1 year. 5. Symptoms highly suggestive of lung cancer, including unexplained weight loss of over 30 pounds (lbs) within the past 12 months or unexplained hemoptysis. * Aim 2: No

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants with detected other cancers (Aim 1)Up to 10 yearsThe proportion of participants with detected cancers, other than lung, will be determined by the frequency of image findings that indicate other cancer, and an ultimate clinical diagnosis associated with the imaging finding.
Proportion of participants with diagnosed interstitial lung disease (Aim 1)Up to 10 yearsInterstitial Lung Disease (ILD) is a group of diseases that irritate, inflame, or scar the lungs and supporting air sacs. The proportion of participants with diagnosed interstitial lung disease will be determined by the frequency of image findings that indicate ILD, and an ultimate clinical diagnosis associated with the imaging finding.
Number of participants within of each Lung-RADS risk groupUp to 10 yearsThe Lung CT Screening Reporting and Data System (Lung-RADS) is a measure developed by the American College of Radiologists to standardize the reporting and management of screen-detected pulmonary nodules. Nodules are categorized as 0=Incomplete, 1=Negative, 2=Benign Appearance or Behavior, 3=Probably Benign, or 4A /4B /4X = Suspicious with an additional modifier of S=Other or C=Prior Lung Cancer to be added to the 4 category codes as needed. The frequency of participants within each Lung-RADS risk group as determined by imaging procedures will be reported.
Proportion of participants with detected lung cancers (Aim 1)Up to 10 yearsThe proportion of participants with detected lung cancers will be determined by the frequency of image findings that indicate lung cancer, and an ultimate clinical diagnosis associated with the imaging finding.
Proportion of participants with occupational lung disease (Aim 1)Up to 10 yearsOccupational or work-related lung diseases are lung conditions that have been caused or made worse by long-term exposure to certain irritants in the workplace. The proportion of participants with occupational lung disease will be determined by the frequency of image findings that indicate occupationally associated lung disease, and an ultimate clinical diagnosis associated with the imaging finding.

Secondary

MeasureTime frameDescription
Number of risk factors identified as associated with cancer developmentUp to 10 yearsThe number of not-yet identified risk factors that are determined to be significantly associated with the development of thoracic cancers will be determined using logistic regression methods.
Percentage of participants with incidental clinical findingsUp to 10 yearsThe percentage of participants with incidental findings be determined by the frequency of image findings that indicate presence of possible coronary calcium, aortic aneurysm, thyroid nodules, liver pathology and osseous pathology and an ultimate clinical diagnosis associated with the imaging finding.

Countries

United States

Contacts

Primary ContactJae Ho Sohn, MD, MS
JaeHo.Sohn@ucsf.edu877-827-3222
Backup ContactAli Nowroozi, MD
Ali.Nowroozi@ucsf.edu877-827-3222

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026